These results collectively show that honokiol-induced LKB1 overexpression is indeed a crucial component of the signaling machinery used by honokiol in modulating the AMPK-S6K axis and inhibiting the metastatic properties of breast cancer cells. This evidence concerns the gene STK11 and breast carcinoma.